What Is JNJ Fair Value?
Johnson & Johnson (JNJ) fair value estimate using multiple valuation models, updated daily.
As of September 15, 2026, Johnson & Johnson (JNJ) has a composite fair value estimate of $217.87 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $267.20, suggesting the stock is overvalued by 18.5%.
Data as of September 15, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$217.87
vs. current price of $267.20(-18.5%)
How Is JNJ Fair Value Calculated?
Four independent models estimate what JNJ is worth. Each uses different inputs and assumptions. The composite blends them by weight.
JNJ Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$320.82
+20.1%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$231.16
-13.5%Fair Value
Inputs used
JNJ Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$93.73
-64.9%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$110.65
-58.6%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $267.20 is 20.1% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $21.47B | $20.32B |
| Year 2 | $22.93B | $20.53B |
| Year 3 | $24.48B | $20.75B |
| Year 4 | $26.14B | $20.98B |
| Year 5 | $27.92B | $21.20B |
| Year 6 | $29.82B | $21.43B |
| Year 7 | $31.84B | $21.65B |
| Year 8 | $34.00B | $21.89B |
| Year 9 | $36.31B | $22.12B |
| Year 10 | $38.78B | $22.35B |
| Terminal Value | $1.26T | $724.63B |
What Are JNJ's Key Financial Metrics?
Earnings & Growth
Current Price
$267.20
EPS (TTM)
$8.63
Forward P/E
21.8
Profit Margin
21.5%
Cash & Balance Sheet
Free Cash Flow
16.9B
EBITDA
34.9B
Book Value
$35.28
Total Debt
49B
What Do Analysts Say About JNJ?
Low
$190.00
Average
$277.91
High
$320.00
Upside
+4.0%
JNJ Fair Value FAQ
What is the fair value of JNJ?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), JNJ's estimated fair value is $217.87. The stock is currently trading at $267.20, which makes it overvalued by our analysis.
How is JNJ's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is JNJ overvalued or undervalued?
Based on our analysis, JNJ is overvalued. The current price of $267.20 is 18.5% above our estimated fair value of $217.87.
What do Wall Street analysts say about JNJ?
22 analysts cover Johnson & Johnson with a consensus rating of "Buy." The average price target is $277.91, ranging from $190.00 to $320.00. This implies 4.0% upside from the current price.